Aug 18: Regeneron Pharmaceuticals Veopoz (pozelimab) secured FDA approval as the first and only treatment indicated specifically for CHAPLE disease, also known as CD55-deficient protein-losing enteropathy, an ultra-rare hereditary disease that can cause potentially life-threatening gastrointestinal and cardiovascular symptoms
There is no evidence that this move has impacted our survey findings and we will continue to monitor any suspected impacts
We'll dive deeper into why this specific type of water is critical, but for now, know that it's the industry standard for reconstitution
A private equity group purchased the company in 1985, and began relocating operations elsewhere
By leveraging advanced research and technology, we can develop more effective, personalized strategies that not only prevent injuries but also optimize overall athletic performance
Maybe you've even used it